| Report ID | 275306 |
| Drug Identification Number | 02241472 |
| Brand name | TAMIFLU |
| Common or Proper name | Oseltamivir |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OSELTAMIVIR |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | Blister pack of 10 |
| Anatomical Therapeutical Chemical (ATC) code | J05AH |
| Anatomical Therapeutical Chemical (ATC) description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-02-22 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2026-02-22 |
| Shortage status | Resolved |
| Updated date | 2026-02-23 |
| Company comments | The anticipated shortage was due to usage of 75mg for compounding purposes with the recent market shortages of Tamiflu Powder for Oral Suspension. This shortage has since been avoided by bringing in additional stock and changing of demand patterns through the seasonal spike in cases of influenza. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2026-02-23 | English | Compare |
| v7 | 2026-02-23 | French | Compare |
| v6 | 2026-02-23 | English | Compare |
| v5 | 2026-02-23 | English | Compare |
| v4 | 2026-02-23 | French | Compare |
| v3 | 2026-02-23 | English | Compare |
| v2 | 2026-01-06 | French | Compare |
| v1 | 2026-01-06 | English | Compare |
Showing 1 to 8 of 8